Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Jacobs

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
The Journal of Gene Medicine|October 25, 2000
HSV-1 infected cell proteins influence tetracycline-regulated transgene expressionU Herrlinger, P A Pechan, A H Jacobs, et al.
Journal of Neuro-Oncology|December 20, 2003
Imaging in gene therapy of patients with gliomaA H Jacobs, J Voges, L W Kracht, et al.
Gene Therapy|May 15, 2007
HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiationO Saydam, N Saydam, D L Glauser, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 22, 2006
Primary stroke unit treatment followed by very early carotid endarterectomy for carotid artery stenosis after acute strokeM Aleksic, M A Rueger, F G Lehnhardt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomasU Herrlinger, C Woiciechowski, M Sena-Esteves, et al.
Neurology|December 14, 2005
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathwaysR Hilker, A V Thomas, J C Klein, et al.
Acta Neurologica Scandinavica|May 6, 2006
Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter diseaseB Bosche, C Dohmen, P Impekoven, et al.
Lupus|May 12, 2006
Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarctionF G Lehnhardt, C Scheid, U Holtik, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastomaA A Brandes, E Franceschi, T Gorlia, et al.
Plos One|December 31, 2013
fMRI guided rTMS evidence for reduced left prefrontal involvement after task practiceJohan Martijn Jansma, Tamar R van Raalten, Ruud Boessen, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
The Journal of Gene Medicine|October 25, 2000
HSV-1 infected cell proteins influence tetracycline-regulated transgene expressionU Herrlinger, P A Pechan, A H Jacobs, et al.
Journal of Neuro-Oncology|December 20, 2003
Imaging in gene therapy of patients with gliomaA H Jacobs, J Voges, L W Kracht, et al.
Gene Therapy|May 15, 2007
HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiationO Saydam, N Saydam, D L Glauser, et al.
Cerebrovascular Diseases (Basel, Switzerland)|June 22, 2006
Primary stroke unit treatment followed by very early carotid endarterectomy for carotid artery stenosis after acute strokeM Aleksic, M A Rueger, F G Lehnhardt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 10, 2000
Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomasU Herrlinger, C Woiciechowski, M Sena-Esteves, et al.
Neurology|December 14, 2005
Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathwaysR Hilker, A V Thomas, J C Klein, et al.
Acta Neurologica Scandinavica|May 6, 2006
Stroke after initiation of interferon-beta treatment for relapsing-remitting disseminated white matter diseaseB Bosche, C Dohmen, P Impekoven, et al.
Lupus|May 12, 2006
Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarctionF G Lehnhardt, C Scheid, U Holtik, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2011
Appropriate end-points for right results in the age of antiangiogenic agents: future options for phase II trials in patients with recurrent glioblastomaA A Brandes, E Franceschi, T Gorlia, et al.
Plos One|December 31, 2013
fMRI guided rTMS evidence for reduced left prefrontal involvement after task practiceJohan Martijn Jansma, Tamar R van Raalten, Ruud Boessen, et al.
Pageof 7